Related Experiment Videos
A severe multisystem reaction to sulindac
1Family Practice Residency Program of Middlesex Memorial Hospital, Middletown, Conn.
Archives of Internal Medicine
|February 1, 1991
Summary
A severe sulindac reaction occurred in a patient with lupus. Subsequent exposure caused anaphylactoid reactions and multi-organ dysfunction, indicating complex hypersensitivity.
Area of Science:
- Immunology
- Pharmacology
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain management.
- Sulindac is an NSAID used to treat pain and inflammation.
Observation:
- A 30-year-old woman with SLE experienced a febrile illness and rash after initial sulindac exposure.
- Readministration of sulindac led to a severe anaphylactoid reaction.
- The patient exhibited cardiovascular, hepatic, pulmonary, and hematologic dysfunction.
Findings:
- The case demonstrates a severe hypersensitivity reaction to sulindac.
- The patient's reaction involved evidence of Types I, II, and III hypersensitivity.
- Sulindac sensitization can lead to multi-organ system involvement.
Implications:
- Clinicians should be aware of potential severe reactions to sulindac, especially in patients with autoimmune conditions.
- Early recognition of drug sensitization is crucial to prevent severe adverse events.
- This case highlights the complex immunological responses that can occur with NSAID administration.